Astellas goes hostile on CV (Dealscape

Japanese drugmaker Astellas Pharma Inc. launched a hostile $16 per share, or $1 billion bid for CV Therapeutics Inc. on Friday after the biotech company rejected its buyout offer.

Astellas and CV Therapeutics already have a marketing partnership, but the Tokyo bidder needs new products to counter the impact of expiring patents on some of its key drugs. So the partner has become the target.

This is a free preview of the content available in The Deal Pipeline. Subscribers enjoy access to the full story, as well as second-to-none research tools.

To request a demo, or, if you are an existing user to The Deal Pipeline, log in to your account, please scroll down and click the button.

Dig deeper, with Pipeline.

754 in-depth reports of M&A deals in the Healthcare sector
569 company pages related to pharmaceuticals
30 articles related to Astellas Pharma Inc.
16 articles related to CV Therapeutics Inc.
10 years of news and analysis archives from the voice of The Deal Economy

Most searched keywords

Skadden Arps
Amusement parks
Deb Shops
Windstream Corp.
Diedrich Coffee
Hanna Andersson
Tween Brands
Entertainment
Lazard
Lyondell Chemical

Forward-looking intelligence allows you time to act. View this video on our restructuring content to see how you can benefit from our expertise.
NOT A SUBSCRIBER? Astellas goes hostile on CV Posted on February 27, 2009 2:54 PM Japanese drugmaker Astellas Pharma Inc. launched a hostile $16 per share, or $1 billion bid for CV Therapeutics Inc. on Friday after the biotech company rejected its buyout offer. Astellas and CV Therapeutics already have a marketing partnership, but the Tokyo bidder needs new products to counter the impact of expiring patents on some of its key drugs. So the partner has become the target. This is a free preview of the content available in The Deal Pipeline. Subscribers enjoy access to the full story, as well as second-to-none research tools. To request a demo, or, if you are an existing user to The Deal Pipeline, log in to your account, please scroll down and click the button. Dig deeper, with Pipeline. 754 in-depth reports of M&A deals in the Healthcare sector 569 company pages related to pharmaceuticals 30 articles related to Astellas Pharma Inc. 16 articles related to CV Therapeutics Inc. 10 years of news and analysis archives from the voice of The Deal Economy Most searched keywords Skadden Arps Amusement parks Deb Shops Windstream Corp. Diedrich Coffee Hanna Andersson Tween Brands Entertainment Lazard Lyondell Chemical		EXISTING USERS Username Password Forget your password? Missing a product?

Sales Contact Michael Crosby mcrosby@thedeal.com 212.313.9325	Media Contact Martha Brown mbrown@thedeal.com 212.313.9218
Signing in signifies that you agree to our terms and conditions. View our privacy policy.